Market Overview The Preclinical CRO Market is witnessing significant growth in oncology and toxicology services, driven by the increasing prevalence of cancer and the stringent regulatory requirements for drug safety testing. Oncology remains the largest therapeutic area for preclinical CROs, with the development of novel immunotherapies, targeted agents, and antibody-drug conjugates...